LSL Pharma Group Inc. LSL.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -81.31% | 167.56% | 94.31% | 165.57% | 1,625.05% |
| Total Receivables | 46.16% | -- | 16.64% | 68.51% | 59.93% |
| Inventory | 32.41% | -- | 40.62% | 130.90% | 134.01% |
| Prepaid Expenses | 110.15% | -- | 24.54% | 29.69% | -34.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.38% | -- | 63.44% | 102.97% | 135.95% |
|
|
|||||
| Total Current Assets | 13.38% | -- | 63.44% | 102.97% | 135.95% |
| Net Property, Plant & Equipment | 47.52% | -- | 49.89% | 26.83% | 36.03% |
| Long-term Investments | 1,439.88% | -- | 4.95% | -- | -- |
| Goodwill | 1,439.88% | -- | 4.95% | -- | -- |
| Total Other Intangibles | 35.04% | -- | 38.16% | 52.07% | 52.23% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.73% | -- | -85.56% | 1,340.54% | 1,321.23% |
| Total Assets | 35.31% | -- | 46.30% | 53.80% | 67.84% |
|
|
|||||
| Total Accounts Payable | 44.49% | -- | 3.89% | 13.73% | 100.46% |
| Total Accrued Expenses | -- | -- | 134.41% | -- | -- |
| Short-term Debt | 7.02% | -- | 3.55% | 1,417.00% | 1,228.99% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 40.87% | -- | -13.74% | -69.82% | -66.17% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.60% | -- | 10.97% | 55.15% | 95.74% |
|
|
|||||
| Total Current Liabilities | 25.60% | -- | 10.97% | 55.15% | 95.74% |
| Long-Term Debt | 87.36% | -- | 119.34% | 129.52% | 130.89% |
| Short-term Debt | 7.02% | -- | 3.55% | 1,417.00% | 1,228.99% |
| Capital Leases | 181.50% | -- | 80.41% | 52.97% | 77.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 71.54% | -- | 87.44% | 5,157.79% | 4,168.08% |
| Total Liabilities | 67.15% | -- | 74.55% | 91.97% | 114.72% |
|
|
|||||
| Common Stock & APIC | 7.46% | -- | 17.40% | 3.41% | 3.93% |
| Retained Earnings | -41.60% | -- | -24.78% | 16.87% | 18.47% |
| Treasury Stock & Other | 51.85% | -- | 65.96% | -- | 0.36% |
| Total Common Equity | -13.49% | -0.02% | 13.71% | 20.84% | 25.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.49% | -0.02% | 13.71% | 20.84% | 25.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.49% | -0.02% | 13.71% | 20.84% | 25.75% |
|
|
|||||